BACKGROUND: The direct oral thrombin inhibitor dabigatran has a predictable anticoagulant effect and may be an alternative therapy to warfarin for patients who have acute venous thromboembolism. METHODS: In a randomized, double-blind, noninferiority trial involving patients with acute venous thrombo...
Research Assistant
AI chat, annotations, notes & similar papers
No comments yet
Be the first to share your thoughts!